β-Cell–Specific Protein Kinase A Activation Enhances the Efficiency of Glucose Control by Increasing Acute-Phase Insulin Secretion

Autor: Michael W. Roe, Lorna M. Dickson, Natalia A. Tamarina, David A. Jacobson, Louis H. Philipson, Barton Wicksteed, Kelly Kaihara
Rok vydání: 2013
Předmět:
medicine.medical_specialty
Patch-Clamp Techniques
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Incretin
030209 endocrinology & metabolism
Biology
Second Messenger Systems
Mice
03 medical and health sciences
0302 clinical medicine
Downregulation and upregulation
Insulin-Secreting Cells
Internal medicine
Insulin Secretion
Cyclic AMP
Internal Medicine
medicine
Animals
Hypoglycemic Agents
Insulin
Phosphorylation
Protein kinase A
Crosses
Genetic

Original Research
030304 developmental biology
0303 health sciences
Venoms
Glucose clamp technique
Cyclic AMP-Dependent Protein Kinases
Up-Regulation
Insulin oscillation
Kinetics
Protein Subunits
Endocrinology
Enzyme Induction
Hyperglycemia
Second messenger system
Glucose Clamp Technique
Commentary
Exenatide
Mutant Proteins
Peptides
Protein Processing
Post-Translational

Signal Transduction
Hormone
Zdroj: Diabetes
ISSN: 1939-327X
0012-1797
Popis: Acute insulin secretion determines the efficiency of glucose clearance. Moreover, impaired acute insulin release is characteristic of reduced glucose control in the prediabetic state. Incretin hormones, which increase β-cell cAMP, restore acute-phase insulin secretion and improve glucose control. To determine the physiological role of the cAMP-dependent protein kinase (PKA), a mouse model was developed to increase PKA activity specifically in the pancreatic β-cells. In response to sustained hyperglycemia, PKA activity potentiated both acute and sustained insulin release. In contrast, a glucose bolus enhanced acute-phase insulin secretion alone. Acute-phase insulin secretion was increased 3.5-fold, reducing circulating glucose to 58% of levels in controls. Exendin-4 increased acute-phase insulin release to a similar degree as PKA activation. However, incretins did not augment the effects of PKA on acute-phase insulin secretion, consistent with incretins acting primarily via PKA to potentiate acute-phase insulin secretion. Intracellular calcium signaling was unaffected by PKA activation, suggesting that the effects of PKA on acute-phase insulin secretion are mediated by the phosphorylation of proteins involved in β-cell exocytosis. Thus, β-cell PKA activity transduces the cAMP signal to dramatically increase acute-phase insulin secretion, thereby enhancing the efficiency of insulin to control circulating glucose.
Databáze: OpenAIRE